This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

CURESPONSE LTD

Profile

Curesponse is a clinical/commercial stage start up, maker of the cResponse, an AI-driven, functional/genomics drug prioritization platform that accurately selects the most effective cancer treatment for each patient. The platform combines rapid next generation sequencing (NGS) with a proprietary functional response assay that assess the response of a cancerous tissue to various drug and drug combinations, while preserving functional Tumor Microenvironment (TME).